Stocks had globally started the week strong, helped by news by Moderna Inc encouraging early test results for a possible coronavirus vaccine, but fell back modestly on Tuesday attributed in part to a press report questioning whether Moderna’s early trials had produced enough data to support evidence for the vaccine’s effectiveness.
United States
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
